2 - Antiviral Therapy Is Effective for EBV Prevention in Pediatric Immunocompromised Hosts: Pro/Con

Wednesday, October 19, 2022

2:05 PM – 2:40 PM US ET

Location: 145 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Speaker(s)

Michael D. Green, MD, MPH

Professor
University of Pittsburgh School of Medicine
Pittsburgh, PA, United States

Disclosure: Disclosure(s): AlloVir: Advisor/Consultant (Ongoing); Bristol Meyer Squibb (BMS): Advisor/Consultant (Ongoing); ITB-MED: Advisor/Consultant (Ongoing)
Elizabeth A. Moulton, MD, PhD

Assistant Professor of Pediatrics
Baylor College of Medicine/Texas Children's Hospital
Houston, Texas, United States

Disclosure: Disclosure(s): Pfizer: Co-investigator for SARS-CoV-2 pediatric vaccine trials ()

Disclosure(s):

Michael D. Green, MD, MPH: AlloVir: Advisor/Consultant (Ongoing); Bristol Meyer Squibb (BMS): Advisor/Consultant (Ongoing); ITB-MED: Advisor/Consultant (Ongoing)

Elizabeth A. Moulton, MD, PhD: Pfizer: Co-investigator for SARS-CoV-2 pediatric vaccine trials ()